BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 7566608)

  • 1. Evaluation of diagnostic criteria for analgesic nephropathy in patients with end-stage renal failure: results of the ANNE study. Analgesic Nephropathy Network of Europe.
    Elseviers MM; Waller I; Nenoy D; Levora J; Matousovic K; Tanquerel T; Pommer W; Schwarz A; Keller E; Thieler H
    Nephrol Dial Transplant; 1995; 10(6):808-14. PubMed ID: 7566608
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diagnostic criteria of analgesic nephropathy in patients with end-stage renal failure: results of the Belgian study.
    Elseviers MM; Bosteels V; Cambier P; De Paepe M; Godon JP; Lins R; Lornoy W; Matthys E; Moeremans C; Roose R
    Nephrol Dial Transplant; 1992; 7(6):479-86. PubMed ID: 1320226
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Is analgesic nephropathy still a problem in Belgium?
    Elseviers MM; De Broe ME
    Nephrol Dial Transplant; 1988; 3(2):143-9. PubMed ID: 3140080
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Incidence of analgesic nephropathy among patients undergoing renal replacement therapy in Czech Republic and Slovak Republic. The Group of Czech and Slovak Nephrologists.
    Matousovic K; Elseviers MM; Devecka D; Horácková M; Turek T; De Broe ME; Nephrologists S
    Nephrol Dial Transplant; 1996 Jun; 11(6):1048-51. PubMed ID: 8671967
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High diagnostic performance of CT scan for analgesic nephropathy in patients with incipient to severe renal failure.
    Elseviers MM; De Schepper A; Corthouts R; Bosmans JL; Cosyn L; Lins RL; Lornoy W; Matthys E; Roose R; Van Caesbroeck D
    Kidney Int; 1995 Oct; 48(4):1316-23. PubMed ID: 8569094
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Analgesic nephropathy in Hungary: the HANS study.
    Pintér I; Mátyus J; Czégány Z; Harsányi J; Homoki M; Kassai M; Kiss E; Kiss I; Ladányi E; Locsey L; Major L; Misz M; Nagy L; Polner K; Rédl J; Solt I; Tichy B; Török M; Varga G; Wagner G; Wórum I; Zsoldos B; Pótó L; Dérczy K; Wittmann I; Nagy J
    Nephrol Dial Transplant; 2004 Apr; 19(4):840-3. PubMed ID: 15031338
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Analgesic nephropathy: an important cause of chronic renal failure.
    Cove-Smith JR; Knapp MS
    Q J Med; 1978 Jan; 47(185):49-69. PubMed ID: 674550
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Analgesic nephropathy in Belgium is related to the sales of particular analgesic mixtures.
    Elseviers MM; De Broe ME
    Nephrol Dial Transplant; 1994; 9(1):41-6. PubMed ID: 8177475
    [TBL] [Abstract][Full Text] [Related]  

  • 9. End-stage renal failure due to analgesic nephropathy, its changing pattern and cardiovascular mortality. EDTA-ERA Registry Committee.
    Brunner FP; Selwood NH
    Nephrol Dial Transplant; 1994; 9(10):1371-6. PubMed ID: 7816247
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bone disease in analgesic nephropathy.
    Fassett RG; Lien JW; McClure J; Mathew TH
    Clin Nephrol; 1982 Dec; 18(6):273-9. PubMed ID: 7151345
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nephropathy as a hazard of analgesic abuse.
    Anandan JV; Matzke GR
    Am J Hosp Pharm; 1981 Oct; 38(10):1536-9. PubMed ID: 7294057
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Analgesic nephropathy].
    Pintér I; Nagy J
    Orv Hetil; 1998 Nov; 139(47):2839-43. PubMed ID: 9846064
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Ultrasound in terminal renal failure--etiologic conclusions?].
    Mostbeck G; Derfler K; Walter R; Herold C; Mallek R; Tscholakoff D
    Ultraschall Med; 1988 Dec; 9(6):250-4. PubMed ID: 3070747
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of legislative measures on the sales of analgesics and the subsequent prevalence of analgesic nephropathy: a comparative study in France, Sweden and Belgium.
    Noels LM; Elseviers MM; de Broe ME
    Nephrol Dial Transplant; 1995; 10(2):167-74. PubMed ID: 7753450
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Over-the-counter analgesic use.
    De Broe ME; Elseviers MM
    J Am Soc Nephrol; 2009 Oct; 20(10):2098-103. PubMed ID: 19423685
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Non-phenacetin analgesics and analgesic nephropathy: clinical assessment of high users from a case-control study.
    Michielsen P; Heinemann L; Mihatsch M; Schnülle P; Graf H; Koch KM
    Nephrol Dial Transplant; 2009 Apr; 24(4):1253-9. PubMed ID: 19037086
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Prevention of analgetics nephropathy].
    Elseviers MM; De Broe ME
    Arch Belg; 1989; 47(1-4):77-80. PubMed ID: 2610578
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Obituary to analgesic nephropathy--an autopsy study.
    Mihatsch MJ; Khanlari B; Brunner FP
    Nephrol Dial Transplant; 2006 Nov; 21(11):3139-45. PubMed ID: 16891638
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Analgesic nephropathy: is it caused by multi-analgesic abuse or single substance use?
    Elseviers MM; De Broe ME
    Drug Saf; 1999 Jan; 20(1):15-24. PubMed ID: 9935274
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combination analgesic involvement in the pathogenesis of analgesic nephropathy: the European perspective.
    Elseviers MM; De Broe ME
    Am J Kidney Dis; 1996 Jul; 28(1 Suppl 1):S48-55. PubMed ID: 8669430
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.